AI driven screening Opportunity to partner with hospitals and clinics in under-resourced regions by offering AI-based eye and systemic disease screening solutions that reduce costly treatments and enable early intervention, supported by iHealthScreen's MHRA certified AI system.

Regulatory momentum Leverage recent MHRA certification for iPredict to approach healthcare networks and distributors in Europe seeking compliant AI diagnostic tools, highlighting faster time-to-market and lower regulatory risk.

Seed to pre-series Capital raise trajectory signals growth and scalability; target potential investors, strategic partners, and healthcare providers looking to co-develop or pilot expanded screening programs in regions with high prevalence of diabetic retinopathy and cardiovascular risk.

Bangladesh expansion Bangladesh operations demonstrate regional deployment capability; pursue regional expansion partnerships, government health programs, and NGO collaborations to scale population-wide screening in South Asia.

Tech stack leverage Highlight existing data and cloud infrastructure (Azure, SQL/NoSQL databases, analytics tools) to white-label or integrate with large providers’ health IT ecosystems, enabling seamless data flow, reporting, and outcomes tracking.